Radiopharm Theranostics Limited American Depositary Shares (RADX) — Financial Flexibility Index

Latest as of December 2025: -0.54x

Radiopharm Theranostics Limited American Depositary Shares (RADX) has a Financial Flexibility Index of -0.54x as of December 2025. Free cash flow of $-22.26 Million (operating CF $-22.26 Million minus capex $4.49) represents -1% of total liabilities ($41.19 Million). Check Radiopharm Theranostics Limited American (RADX) strategic investment index to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

-0.54x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-22.26 Million
Operating CF − Capex

Total Liabilities

$41.19 Million
USD

Capital Expenditures

$4.49
USD

Radiopharm Theranostics Limited American Depositary Shares Financial Flexibility Index (2022–2025)

Historical Financial Flexibility Index trend for Radiopharm Theranostics Limited American Depositary Shares across 4 annual periods. See Radiopharm Theranostics Limited American (RADX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Radiopharm Theranostics Limited American Depositary Shares (2022–2025)

Year-by-year free cash flow to debt coverage for Radiopharm Theranostics Limited American Depositary Shares. For the full company profile including market capitalisation, see how much is Radiopharm Theranostics Limited American worth.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -0.84x $-36.65 Million $-36.65 Million $43.61 Million ▼ -63.4%
2024 -0.51x $-22.98 Million $-22.98 Million $44.68 Million ▲ +30.3%
2023 -0.74x $-21.67 Million $-23.20 Million $29.37 Million ▼ -181.8%
2022 0.90x $18.42 Million $-9.92 Million $20.42 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities